SHERYL ZAYAS: Open Payments
NPI 1598034167 · WILTON MANORS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,658 in 66 payments from 13 companies in 2025. Trend: 2023 $1,883 · 2024 $2,005 · 2025 $1,658
Food & beverage: $1,658
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 29 | $686 |
| Gilead Sciences, Inc. | 16 | $440 |
| Theratechnologies Inc. | 5 | $175 |
| Indivior Inc. | 4 | $120 |
| Braeburn Inc. | 4 | $68 |
| Neurocrine BioSciences, Inc. | 1 | $33 |
| Astellas Pharma US Inc | 1 | $31 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| EMD Serono, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: DOVATO, EGRIFTA, CABENUVA, APRETUDE, RUKOBIA, SUBLOCADE, BRIXADI, INGREZZA.
Industry payments across FL — which companies pay providers there.
